/The French trust vaccines less and less
The French Trust Vaccines Less And Less

The French trust vaccines less and less

In all, 69% of respondents trust vaccines, according to a survey conducted for the pharmaceutical industry.

A patient receives an influenza vaccine on October 8, 2015, in Lille.  (PHILIPPE HUGUEN / AFP)

Vaccines are the subject of growing skepticism on the part of the French. According to an annual study *, published Monday, October 24, only 69% of people questioned trust vaccines. This is the lowest rate since the launch of the Societal Medicines Observatory, carried out since 2012 by the Ipsos institute for the French organization of industrialists in the sector, Leem.

Half (52%) of those surveyed consider that vaccination has more benefits than risks, 33% believing that it includes as many of both and 15% more than risks than benefits, according to this study. However, these perceptions vary from one generation to another: the 25-34 year old generation is thus the most suspicious, and the 55-59 year old the most confident. Of all those surveyed, 34% say they are not sure they are up to date with their vaccination and 6% have no idea.

Distrust of drugs in general

But the mistrust of the French is also increasing for most categories of drugs as for health professionals. For drugs in general, 84% of respondents say they have confidence, a level remaining high but down by one point over one year. An erosion appears in almost all of the categories, in particular prescription drugs (-5 points) and reimbursed drugs (-4 points), two categories which, however, remain at a very high level of confidence (88%). Only homeopathy progressed (73%, +2 points), while generics remained stable compared to 2015, at 68%.

Confidence in health professionals to provide information on medicines also remains high (from 88% for pharmacists to 93% for treating physicians) but declines over one year, while that granted to whistleblowers has exploded (69%, +24 points).

* The survey was carried out with a representative sample of 1,000 people in France, interviewed online from June 9 to 16, 2016.